Nanobiotix Launches Approximately €75M Global Follow-On Offering
Nanobiotix announces the launch, subject to market and other conditions, of an approximately EUR 75M global follow-on offering consisting of (i) a public offering of its American Depositary Shares, each ADS representing one ordinary share, EUR0.03 nominal value per share, of the company, in the United States and (ii) an offering of (a) its Ordinary Shares and (b) pre-funded warrants to subscribe for Ordinary Shares, exclusively addressed to "qualified investors" in Europe within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended, and certain other countries. Jefferies, TD Cowen and Stifel are acting as global coordinators and joint bookrunners for the Global Offering.
